GENERIUM is a full—cycle Russian innovative research and production company, a leader in the orphan segment of the Russian pharmaceutical market. The company meets the needs of the Russian healthcare system in medicines, means of prevention and diagnosis of complex hereditary, socially significant diseases.
The company's own R&D park is capable of developing medicines from the creation of a molecule to the start of industrial production in accordance with international GLP and GCP standards. The production sites are organized in strict accordance with international GMP standards.